Target intelligence / Profile preview

IFITM3 antisense RNA 1 (IFITM3-AS1)

Target
IFITM3-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

IFITM3 antisense RNA 1 (IFITM3-AS1) is a long non-coding RNA gene transcribed in the antisense direction relative to the IFITM3 gene, which encodes interferon-induced transmembrane protein 3 (IFITM3). Unlike its protein-coding counterpart, IFITM3-AS1 is not translated into a protein and instead is thought to participate in the regulation of gene expression, potentially through antisense-mediated modulation of IFITM3 or nearby genomic elements. Long non-coding RNAs such as IFITM3-AS1 are increasingly recognized for their roles in epigenetic and transcriptional regulation but are not classical therapeutic targets like receptors or enzymes. Currently, there is limited published information on disease-specific roles, functional characterization, or targeting strategies for IFITM3-AS1. Additional relevant context: - The protein-coding IFITM3 gene encodes a small transmembrane protein that plays a significant role in host antiviral defense; however, this is distinct from the non-coding antisense RNA IFITM3-AS1. - Long non-coding RNAs like IFITM3-AS1 are studied for their potential as diagnostic or prognostic markers, but no established clinical use is reported for this gene. If you seek information on the protein-coding IFITM3 target, please clarify, as it is functionally distinct and widely studied in antiviral immunity.

Other names
IFITM3-AS1
02

Biological functions

Potential gene expression regulation (antisense regulation of IFITM3)Possible involvement in RNA-mediated transcriptional or post-transcriptional regulation
03

Disease associations

There is currently no strong evidence from the available results or major reviews linking IFITM3-AS1 specifically to cancer, infection, or other diseases, but lncRNAs/antisense RNAs frequently play roles in gene regulatory networks relevant to disease.

Beyond the preview

Go deeper on IFITM3 antisense RNA 1 (IFITM3-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on IFITM3 antisense RNA 1 (IFITM3-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call